Navigation Links
Antifolate Drugs may Be Effective in Treating P Vivax Malaria

Researchers of HealthNet TPO Malaria and Leishmaniasis Control Programme in Pakistan, have revealed that antifolate drugs may be effective in treating P vivax malaria.

Toby Leslie, M.Sc., and colleagues tested the relative efficacy and safety of two antifolate drugs (sulfadoxine-pyrimethamine and chlorproguanil-dapsone) against P vivax malaria and compared each with chloroquine.

There are an estimated 70 million to 80 million cases of P vivax each year, accounting for more than 50 percent of all malaria cases outside Africa. Although rarely fatal, it is a major cause of illness. P vivax malaria was thought to be resistant to treatment with antifolates, an affordable antimalarial class.

The study included 767 patients (315 from Pakistan and 452 from Afghanistan) with P vivax malaria. The researchers found that although chloroquine remains the drug of choice, all three therapies effectively cleared parasites by day 14 and were well tolerated.

"These drugs may be appropriate for unified treatment where species-specific diagnosis is unavailable, most likely in combination with other drugs, said the researchers.


'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, a leading ... Denise Flannery, to its strategic advisory and client development team. , In ... with clients across different industries to develop and implement market-justified strategies, modernize and ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... has joined its executive team as the President of its HealthBI division. ... management systems and contact centers. , “Scott is a utility player who ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has introduced ... When we’re born, Nature gives us a full supply of melanin – in ... continuously lose this natural glare-reducing pigment; however, around the age of thirty, we develop ...
(Date:9/19/2017)... ... September 19, 2017 , ... Bringing ... the MirixaPro 6.0 platform. As the industry’s leading Medication Therapy Management solution, ... Based on industry research and market feedback, the latest version of MirixaPro ...
(Date:9/19/2017)... ... 2017 , ... Back Pain Centers of America ... with a reputable physician in their area, announces the addition of Allegion Spine ... Spine Clinic was founded by board-certified spine surgeon, Jaswinder Grover, M.D. , ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
(Date:9/12/2017)... -- Consumer reviews on the independent review site Consumer Affairs ... for hearing aids, ranking it higher than Miracle Ear ™, ... ... Hearing Aids ... store that provides high performance, state-of-the-art, German-engineered hearing aids directly to ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
Breaking Medicine Technology: